Cover Image

A humanized Caenorhabditis elegans model of hereditary spastic paraplegia-associated variants in KLC4

Saved in:

Bibliographic Details
Main Authors:	Selin Gümüşderelioğlu (Author), Lauren Resch (Author), Trisha Brock (Author), Undiagnosed Diseases Network (Author), G. W. Gant Luxton (Author), Heidi Cope (Author), Queenie K.-G. Tan (Author), Christopher Hopkins (Author), Daniel A. Starr (Author)
Format:	Book
Published:	The Company of Biologists, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modeling neurodegeneration in Caenorhabditis elegans
by: Kim A. Caldwell, et al.
Published: (2020)

Mechanisms of iron metabolism in Caenorhabditis elegans
by: Elizabeth A Leibold, et al.
Published: (2014)

Caenorhabditis elegans for research on cancer hallmarks
by: Julián Cerón
Published: (2023)

Chapter Advanced Microfluidic Assays for Caenorhabditis elegans
by: Bakhtina, Natalia A.
Published: (2016)

Chapter Advanced Microfluidic Assays for Caenorhabditis elegans
by: Bakhtina, Natalia A.
Published: (2016)

Drug discovery: Insights from the invertebrate Caenorhabditis elegans
by: Sebastián Giunti, et al.
Published: (2021)

Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans
by: Se-Myeong Cheon, et al.
Published: (2017)

Mapping resistance-associated anthelmintic interactions in the model nematode Caenorhabditis elegans.
by: Elena G Rehborg, et al.
Published: (2023)

Modelling brain dopamine-serotonin vesicular transport disease in Caenorhabditis elegans
by: Alexander T. Young, et al.
Published: (2018)

A review of the reproductive toxicity of environmental contaminants in Caenorhabditis elegans
by: Yunjiang Yu, et al.
Published: (2022)

Curcumin supplementation increases longevity and antioxidant capacity in Caenorhabditis elegans
by: Jianing Xu, et al.
Published: (2023)

Role of Presenilin in Mitochondrial Oxidative Stress and Neurodegeneration in Caenorhabditis elegans
by: Shaarika Sarasija, et al.
Published: (2018)

Study on Caenorhabditis Elegans as a Combined Model of Microdosimetry and Biology
by: Wentao Yu, et al.
Published: (2021)

Bisphosphonates attenuate age‐related muscle decline in Caenorhabditis elegans
by: Luke Slade, et al.
Published: (2023)

Functional distinction in oncogenic Ras variant activity in Caenorhabditis elegans
by: Haimeng Lyu, et al.
Published: (2024)

Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans
by: Carmen Martínez-Fernández, et al.
Published: (2022)

Antiaging effect of a Jianpi-yangwei formula in Caenorhabditis elegans
by: Liling Zeng, et al.
Published: (2019)

Interpreting the pathogenicity of Joubert syndrome missense variants in Caenorhabditis elegans
by: Karen I. Lange, et al.
Published: (2021)

Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
by: Francisco Javier García-Rodríguez, et al.
Published: (2018)

Prediction of biological age by morphological staging of sarcopenia in Caenorhabditis elegans
by: Ineke Dhondt, et al.
Published: (2021)

Online monitoring of focal spasticity treatment with botulinum toxin in people with chronic stroke or hereditary spastic paraplegia: a feasibility study
by: Hans C. J. W. Kerstens, et al.
Published: (2023)

Expanding the phenotype of spastic paraplegia 26: Report of 4 cases with hearing dysfunction
by: Carolina Lopes, et al.
Published: (2019)

TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
by: Caitlin S. Latimer, et al.
Published: (2022)

Variants in PRKCE and KLC1, Potential Regulators of Type I Psoriasis
by: Xing J, et al.
Published: (2022)

Neurite Branching Regulated by Neuronal Cell Surface Molecules in Caenorhabditis elegans
by: HoYong Jin, et al.
Published: (2020)

Beneficial effect of Xuebijing against Pseudomonas aeruginosa infection in Caenorhabditis elegans
by: Le Zhang, et al.
Published: (2022)

Santalol Isomers Inhibit Transthyretin Amyloidogenesis and Associated Pathologies in Caenorhabditis elegans
by: Amirthalingam Mohankumar, et al.
Published: (2022)

Metabolic and behavioral effects of olanzapine and fluoxetine on the model organism Caenorhabditis elegans
by: Abdullah Almotayri, et al.
Published: (2021)

The Evaluation of Geroprotective Effects of Selected Flavonoids in Drosophila melanogaster and Caenorhabditis elegans
by: Ekaterina Lashmanova, et al.
Published: (2017)

Simira cordifolia protects against metal induced-toxicity in Caenorhabditis elegans
by: Margareth Duran-Izquierdo, et al.
Published: (2023)

Back to the future through the wormhole: Caenorhabditis elegans as a preclinical model
by: Guy A. Caldwell
Published: (2023)

The toxicity assessment of extract of Peganum harmala L. seeds in Caenorhabditis elegans
by: Xiangzhen Miao, et al.
Published: (2020)

Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths
by: Peter A. Kropp, et al.
Published: (2021)

Neuraxial anesthesia for a laboring patient with hereditary spastic paraplegia: A case report
by: Joshua Falescky, et al.
Published: (2022)

Complicated Hereditary Spastic Paraplegia Caused by SERAC1 Variants in a Chinese Family
by: Dandan Yan, et al.
Published: (2022)

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations
by: Greger Abrahamsen, et al.
Published: (2013)

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations
by: Greger Abrahamsen, et al.
Published: (2015)

Altered expression of KLC3 may affect semen parameters
by: Pegah Kargar- Dastjerdy, et al.
Published: (2016)

Classification and prediction of toxicity of chemicals using an automated phenotypic profiling of Caenorhabditis elegans
by: Shan Gao, et al.
Published: (2018)

Oxidation and Antioxidation of Natural Products in the Model Organism <i>Caenorhabditis elegans</i>
by: An Zhu, et al.
Published: (2022)